# 2025-05528: Ohio Doctor Loses DEA License Over State Permission Snag

2025-05528, Mary Massullo, D.O.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-04-01, effective 2025-05-01; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-05528
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-05528
- Title: Mary Massullo, D.O.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 14390
- Published: 2025-04-01
- Effective: 2025-05-01
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Ohio Doctor Loses DEA License Over State Permission Snag

## Summary

Mary Massullo, D.O., lost her license to handle controlled substances because she no longer has permission from Ohio, where she’s registered. She didn’t ask for a hearing, so the DEA decided to revoke her registration officially. This means she can’t legally work with controlled drugs anymore, and her registration expired on January 31, 2025.

## Effects PRIA read

- DEA Registration Revoked After State License Loss: cost, high. If you are a DEA registrant who no longer has authority to practice medicine in the State where you are registered, the DEA will revoke your DEA Certificate of Registration and deny any pending renewal or additional registration applications in that State. In this case, DEA revoked Registration No.…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-05528 on federalregister.gov](https://www.federalregister.gov/documents/2025/04/01/2025-05528/mary-massullo-do-decision-and-order)
- [2025-05528 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-04-01/pdf/2025-05528.pdf)

## Related
- [Previous: 2025-05527, Baijes Bissonnet Pharmacy; Decision and Order](https://policyrisk.com/federal-register/2025-05527)
- [Next: 2025-05529, Eunice Kennedy Shriver National Institute of Child Health & Human Development;…](https://policyrisk.com/federal-register/2025-05529)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-05528 (as of 2026-06-08).
